Kiora Pharmaceuticals (KPRX) Gains from Investment Securities (2018 - 2025)
Kiora Pharmaceuticals' Gains from Investment Securities history spans 7 years, with the latest figure at $1227.0 for Q4 2025.
- For Q4 2025, Gains from Investment Securities changed N/A year-over-year to $1227.0; the TTM value through Dec 2025 reached $336507.0, changed N/A, while the annual FY2025 figure was $336507.0, N/A changed from the prior year.
- Gains from Investment Securities reached $1227.0 in Q4 2025 per KPRX's latest filing, down from $1603.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.4 million in Q3 2022 to a low of $1227.0 in Q4 2025.
- Average Gains from Investment Securities over 3 years is $289918.6, with a median of $130865.0 recorded in 2021.
- Peak YoY movement for Gains from Investment Securities: tumbled 95.19% in 2021, then soared 11907.94% in 2022.
- A 3-year view of Gains from Investment Securities shows it stood at $428480.0 in 2021, then skyrocketed by 232.59% to $1.4 million in 2022, then crashed by 99.91% to $1227.0 in 2025.
- Per Business Quant, the three most recent readings for KPRX's Gains from Investment Securities are $1227.0 (Q4 2025), $1603.0 (Q3 2025), and $219061.0 (Q2 2025).